Related Experiment Video
Updated: Apr 23, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.0K
Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development
Changsung Kim1, Hee Chul Lee1, Jung-Joon Sung2
1Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea.
Experimental Neurobiology
|September 27, 2014
Summary
Cell-based therapies offer new hope for treating amyotrophic lateral sclerosis (ALS), a motor neuron disease. Ongoing trials explore stem cells for regenerating motor neurons and advancing ALS treatment options.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss.
- Current treatments offer minimal delay in disease progression, necessitating novel therapeutic strategies.
- Cell-based therapy is a promising approach for regenerating motor neurons in ALS patients.
Purpose of the Study:
- To review recent advancements in cell transplant therapies for ALS.
- To discuss the potential of induced pluripotent stem cells (iPSCs) in ALS treatment and drug screening.
- To provide an outlook on future therapeutic options for ALS.
Main Methods:
- Review of current literature on cell-based therapies for ALS.
- Analysis of recent human trials involving non-autologous fetal spinal stem cells.
- Evaluation of ongoing autologous somatic stem cell trials.
- Discussion of induced pluripotent stem cell (iPSC) applications in ALS drug discovery and transplantation.
Main Results:
- Non-autologous fetal spinal stem cell transplants have shown promise in initial ALS patient trials.
- Autologous somatic stem cell trials are underway, with outcomes anticipated to guide future treatments.
- iPSC technology offers potential for both drug screening and autologous cell transplantation in ALS.
Conclusions:
- Cell-based therapies, including stem cell transplants, represent a significant advancement in ALS treatment research.
- iPSC technology is poised to expand therapeutic avenues for ALS, offering personalized treatment and drug development platforms.
- Further clinical trials and research are crucial to fully realize the potential of these innovative approaches for curing ALS.
More Related Videos
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
12.3K
04:45Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
456
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
00:59Gene Therapy
22.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.0K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:20Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K